-
3
-
-
0031965254
-
Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE). SLE and Sjögren's syndrome (SS), and primary SS
-
Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE). SLE and Sjögren's syndrome (SS), and primary SS. J Rheumatol 1998;25:63-8.
-
(1998)
J Rheumatol
, vol.25
, pp. 63-68
-
-
Sutcliffe, N.1
Stoll, T.2
Pyke, S.3
Isenberg, D.A.4
-
4
-
-
0033601774
-
Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren's syndrome
-
Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren's syndrome. Arch Intern Med 1999;159:174-81.
-
(1999)
Arch Intern Med
, vol.159
, pp. 174-181
-
-
Vivino, F.B.1
Al-Hashimi, I.2
Khan, Z.3
-
5
-
-
0034617662
-
Cevimeline (Evoxac) for dry mouth
-
Anonymous. Cevimeline (Evoxac) for dry mouth. Med Lett Drugs Ther 2000;42:70.
-
(2000)
Med Lett Drugs Ther
, vol.42
, pp. 70
-
-
-
6
-
-
0027954030
-
Topical cyclosporine treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome
-
Gunduz K, Ozdemir O. Topical cyclosporine treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol (Copenh) 1994;72:438-42.
-
(1994)
Acta Ophthalmol (Copenh)
, vol.72
, pp. 438-442
-
-
Gunduz, K.1
Ozdemir, O.2
-
7
-
-
0033174272
-
Treatment of primary Sjögren's syndrome with low-dose natural interferon-alpha administered by the oral mucosal route: A phase II clinical trial
-
IFN Protocol Study Group
-
Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB. Treatment of primary Sjögren's syndrome with low-dose natural interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. J Interferon Cytokine Res 1999;19:943-51.
-
(1999)
J Interferon Cytokine Res
, vol.19
, pp. 943-951
-
-
Ship, J.A.1
Fox, P.C.2
Michalek, J.E.3
Cummins, M.J.4
Richards, A.B.5
-
8
-
-
0031900178
-
Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome
-
Shiozawa S, Tanaka Y, Shiozawa K. Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome. J Interferon Cytokine Res 1998;18:255-62.
-
(1998)
J Interferon Cytokine Res
, vol.18
, pp. 255-262
-
-
Shiozawa, S.1
Tanaka, Y.2
Shiozawa, K.3
-
9
-
-
0031899338
-
Weak association between subjective symptoms and objective testing for dry eyes and dry mouth: Results from a population based study
-
Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998;57:20-4.
-
(1998)
Ann Rheum Dis
, vol.57
, pp. 20-24
-
-
Hay, E.M.1
Thomas, E.2
Pal, B.3
Hajeer, A.4
Chambers, H.5
Silman, A.J.6
-
10
-
-
0343963066
-
Reliability and validity of the ocular surface disease index
-
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615-21.
-
(2000)
Arch Ophthalmol
, vol.118
, pp. 615-621
-
-
Schiffman, R.M.1
Christianson, M.D.2
Jacobsen, G.3
Hirsch, J.D.4
Reis, B.L.5
-
12
-
-
0027523652
-
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community
-
Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
-
(1993)
Arthritis Rheum
, vol.36
, pp. 340-347
-
-
Vitali, C.1
Bombardieri, S.2
Moutsopoulos, H.M.3
-
13
-
-
0000718721
-
The European classification criteria for Sjögren's syndrome. Proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristic curve of the criteria performance
-
Vitali C, Bombardieri S. The European classification criteria for Sjögren's syndrome. Proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristic curve of the criteria performance [abstract]. J Rheumatol 1997;24 Suppl 50:38.
-
(1997)
J Rheumatol
, vol.24
, Issue.SUPPL. 50
, pp. 38
-
-
Vitali, C.1
Bombardieri, S.2
-
14
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
-
15
-
-
0020436689
-
The 1982 revised criteria for the classification of systemic lupus erythematosus
-
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
-
(1982)
Arthritis Rheum
, vol.25
, pp. 1271-1277
-
-
Tan, E.M.1
Cohen, A.S.2
Fries, J.F.3
-
16
-
-
0024636154
-
Workshop on diagnostic criteria for Sjögren's syndrome
-
Vitali C, editor. Workshop on Diagnostic Criteria for Sjögren's Syndrome. Clin Exp Rheumatol 1989;7 Suppl:111-219.
-
(1989)
Clin Exp Rheumatol
, vol.7
, Issue.SUPPL.
, pp. 111-219
-
-
Vitali, C.1
-
17
-
-
0034771342
-
Perspectives on outcome measures in primary Sjögren's syndrome
-
Bowman SJ, Pillemer S, Jonsson R, et al. Perspectives on outcome measures in primary Sjögren's syndrome. Rheumatology 2001;40:1180-8.
-
(2001)
Rheumatology
, vol.40
, pp. 1180-1188
-
-
Bowman, S.J.1
Pillemer, S.2
Jonsson, R.3
-
18
-
-
0034543806
-
Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome
-
Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. Scand J Rheumatol 2000;29:341-8.
-
(2000)
Scand J Rheumatol
, vol.29
, pp. 341-348
-
-
Jonsson, R.1
Haga, H.J.2
Gordon, T.P.3
-
19
-
-
0032948151
-
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
-
Wolfe F, Lassere M, van der Heijde DMFM, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999;26:484-9.
-
(1999)
J Rheumatol
, vol.26
, pp. 484-489
-
-
Wolfe, F.1
Lassere, M.2
Van der Heijde, D.M.F.M.3
|